Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Comorbidity
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Young people, students and families
Health consequences
Comorbidity — Crime
Comorbidity — Mental health
Stimulants — Comorbidity
Youth — Comorbidity
Wednesday, 23 October
13:20
Treatment — challenges, determinants and responses
13:20
to
14:50
Networking zone 3 (N3)
Dominique Lopez
15:00
Therapeutic horizons I
15:00
to
16:30
Networking zone 1 (N1)
Wouter Vanderplasschen
16:50
Alcohol: short communications on policy and treatment
16:50
to
18:20
Networking zone 3 (N3)
Jorgen G. Bramness
Theoretical and epidemiological considerations in gambling and other behavioural addictions
16:50
to
18:20
Central square 2 (C2)
Simon Marmet
Thursday, 24 October
10:50
Methods and approaches to inform drug policy and practice
10:50
to
12:20
Networking zone 4 (N4)
Márya Hynes
Understanding behaviours, risks and harms
10:50
to
12:20
Networking zone 3 (N3)
Xavier Majó
13:20
Cannabis — risks and responses
13:20
to
14:50
Networking zone 4 (N4)
Jennifer Price
15:00
Preclinical models and biomarkers
Exploring comorbidities in addiction
15:00
to
16:30
Insights zone 2 (I2)
Fernando Rodriguez de Fonseca
Friday, 25 October
10:45
Treatment — improving standards and outcomes
10:45
to
12:15
Networking zone 3 (N3)
Gerhard Bühringer
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
13:30
Short communication
Treating drug abuse and health issues in the criminal justice system. An empirical research on the linkage of health and criminal justice interventions, France
13:30
to
13:40
Networking zone 3 (N3)
Ivana Obradovic
Short communication
Perceptions on social determinants of opioid dependence recovery
13:30
to
13:40
Networking zone 3 (N3)
Leonor Brito
13:40
Short communication
Reverse transition from injecting to smoking heroin and/or crack cocaine on lower methadone dose: sub-therapeutic dosing or safer drug use?
13:40
to
13:50
Networking zone 3 (N3)
Felicia Heidebrecht
13:50
Short communication
Benzodiazepine management in primary care: barriers and facilitators
13:50
to
14:00
Networking zone 3 (N3)
Kristien Coteur
14:00
Short communication
Referral of European and third country non-national clients in Belgian drug treatment
14:00
to
14:15
Networking zone 3 (N3)
Eva Blomme
14:10
Short communication
HIV and drug abuse: relationship and treatment challenges
14:10
to
14:20
Networking zone 3 (N3)
Sara Dehanov
14:20
Short communication
Motivation for treatment predict adherence to treatment in a randomised clinical trial
14:20
to
14:30
Networking zone 3 (N3)
Zhanna Gaulen
14:30
Short communication
Psychiatric assessment of prisoners in opioid-maintenance treatment: emphasis on ADHD
14:30
to
14:40
Networking zone 3 (N3)
Marisa Silbernagl
14:40
Short communication
Perceptions on social determinants of opioid dependence recovery
14:40
to
14:50
Networking zone 3 (N3)
15:10
Oral presentation
A peer-led integrated approach for co-existing mental and addictive disorders: a longitudinal qualitative study of the first UK dual diagnosis anonymous
15:10
to
15:25
Networking zone 1 (N1)
Raffaella Margherita Milani
15:25
Oral presentation
m-Health among illicit drug users: effectiveness, differential indication, risks and negative effects and ongoing developments among guided and unguided interventions
15:25
to
15:40
Networking zone 1 (N1)
Michael Schaub
15:40
Oral presentation
Associations of ketamine use with mental health and substance use outcomes at 12 months follow-up in young Europeans
15:40
to
15:55
Networking zone 1 (N1)
Meryem Grabski
15:55
Oral presentation
The acceptability of psychedelics as treatment options in psychiatry. Data from GDS2019
15:55
to
16:10
Networking zone 1 (N1)
Adam Winstock
16:10
Oral presentation
Effectiveness and cost-effectiveness of adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
16:10
to
16:25
Networking zone 1 (N1)
John Marsden
16:50
Short communication
If you work, don't drink - Association between alcohol consumption patterns and work-related injuries in Portugal
16:50
to
18:20
Networking zone 3 (N3)
Duarte Vital Brito
17:00
Short communication
Which internalising disorders associate with harmful alcohol use in late adolescence and early adulthood: results from population-based UK sample
17:00
to
17:10
Networking zone 3 (N3)
Gwen Fernandes
Oral presentation
Challenges of individual responsibility in (addicted) gambling: a philosophical analysis
17:00
to
17:15
Central square 2 (C2)
Susanne Uusitalo
17:10
Short communication
Neuropsychological diagnostics of higher mental functions in patients with alcohol dependence (Pilot study)
17:10
to
17:20
Networking zone 3 (N3)
Eugenia Fadeeva
17:15
Oral presentation
The prevalence of problematic Internet use in Malta among young persons aged 13–16 years: a quantitative research study
17:15
to
17:30
Central square 2 (C2)
Anna Maria Vella
17:20
Short communication
Community-based alcohol prevention for youth – Evaluation of best practice implementation and local capacity building in the project 'Localize it!'
17:20
to
17:30
Networking zone 3 (N3)
Silke Diestelkamp
17:30
Short communication
Real-time drinking, age of drinking onset, and other drug use predict the adverse alcohol use consequences of tertiary students
17:30
to
17:40
Networking zone 3 (N3)
Rob Hester
Oral presentation
Unique versus shared associations of substance use disorders and behavioural addictions with major depression: a commonality analysis in a large sample of young Swiss men
17:30
to
17:45
Central square 2 (C2)
Simon Marmet
17:40
Short communication
Availability of research data in high-impact alcohol and drug journals with data sharing policies
17:40
to
17:50
Networking zone 3 (N3)
Dennis Gorman
17:45
Oral presentation
Psychobiological approach to pathological and problematic gambling and gaming: systematic literature review
17:45
to
18:00
Central square 2 (C2)
Artemisa R. Dores
18:00
Oral presentation
Evaluation of the gambling disorder construct
18:00
to
18:15
Central square 2 (C2)
Jabulanis Maphisa Maphisa
Thursday, 24 October
11:00
Short communication
Quantitative and qualitative evidences for better gender-based prevention of adolescent addictive behaviours, with and without substance
11:00
to
11:10
Networking zone 4 (N4)
Patricia Gómez
Short communication
Neuropsychological functioning, psychopathology, and parenting behaviours in the context of substance use disorders: which are the implications for treatment?
11:00
to
11:10
Networking zone 3 (N3)
Alessio Porreca
11:10
Short communication
The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium
11:10
to
11:20
Networking zone 4 (N4)
Lies Gremeaux
Short communication
Childhood adversity within adolescent friendship groups: Implications for subsequent substance use disorders
11:10
to
11:20
Networking zone 3 (N3)
Lauren Bishop
11:20
Short communication
From chronology to processes: combining biographical interview with episodic analysis in a life story
11:20
to
11:30
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
Short communication
Cause-specific hospitalisation and death in a cohort of people who use heroin and crack cocaine in London, England: the importance of non-communicable diseases, skin infections, head injuries and dental caries
11:20
to
11:40
Networking zone 3 (N3)
Dan Lewer
11:30
Short communication
Coding multiple drug use in ICD-10 and ICD-11
11:30
to
11:40
Networking zone 4 (N4)
Espen Walderhaug
Short communication
Yearning to be better than good –Lithuanian students of medicine use of cognitive enhancers among
11:30
to
11:40
Networking zone 3 (N3)
Aiste Lengvenyte
11:40
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
Short communication
New issues regarding drug-related deaths: combined suicide
11:40
to
11:50
Networking zone 3 (N3)
Mateja Jandl
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Daniela Filipa Ferreira
11:50
Short communication
The role of the juveniles in the structure and dynamics of the illegal drug market in the Republic of Croatia
11:50
to
12:00
Networking zone 4 (N4)
Short communication
Women and HIV in prison setting: data from the Italian ROSE network
11:50
to
12:00
Networking zone 3 (N3)
12:00
Short communication
Non-national clients in Belgian drug treatment: different profile characteristics compared to Belgian clients
12:00
to
12:10
Networking zone 3 (N3)
Charlotte De Kock
Short communication
Lifetime prevalence of drug use before imprisonment in Europe: results from a systematic literature review
12:00
to
12:10
Networking zone 4 (N4)
12:10
Short communication
Public participation in effective development of a regional drug strategy: experiences from the South East region of Ireland
12:10
to
12:20
Networking zone 4 (N4)
Michelle Foley
13:30
Short communication
Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CNR1 receptor and FAAH enzyme
13:30
to
13:40
Networking zone 4 (N4)
Chandni Hindocha
13:40
Short communication
Psychological aspects of cannabis use disorder: a review of the theory and implications for psychotherapy
13:40
to
13:50
Networking zone 4 (N4)
Daniel Feingold
13:50
Short communication
Intention to reduce cannabis use and help-seeking attitudes in Dutch frequent cannabis users.
13:50
to
14:00
Networking zone 4 (N4)
Marleen Olthof
14:00
Short communication
Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth.
14:00
to
14:10
Networking zone 4 (N4)
Cesar Leos-Toro
14:10
Short communication
Cannabis use in early adulthood and later prescription of antipsychotics, mood stabilisers, antidepressants and anxiolytics.
14:10
to
14:20
Networking zone 4 (N4)
Eline Rognli
14:20
Short communication
Have chronic cannabis consumers developed tolerance to the residual effects of recent cannabis use?
14:20
to
14:30
Networking zone 4 (N4)
Raimondo Bruno
14:30
Short communication
Sociodemographic and educational characteristics of cannabis users attending outpatient treatment centres: implications for psychoeducational intervention
14:30
to
14:40
Networking zone 4 (N4)
Samuel Rueda
14:40
Short communication
Can cannabis use cause death in humans ?
14:40
to
14:50
Networking zone 4 (N4)
Mateja Jandl
15:10
Oral presentation
Bioinformatics approach to dual diagnosis: the Psygenet project
15:10
to
15:25
Insights zone 2 (I2)
Olga Valverde
15:25
Oral presentation
Dual depression and Triptophan metabolites
15:25
to
15:40
Insights zone 2 (I2)
Francina Fonseca
15:40
Oral presentation
Depression, microbiota and alcohol use disorder: the gut connection
15:40
to
15:55
Insights zone 2 (I2)
Laura Orio
15:55
Oral presentation
Alcohol acceleration of cognitive impairment in preclinical models
15:55
to
16:10
Insights zone 2 (I2)
Marta Rodriguez-Arias
16:10
Oral presentation
Exploring comorbidities in addiction
16:10
to
16:20
Insights zone 2 (I2)
Fernando Rodriguez de Fonseca
Friday, 25 October
10:55
Short communication
Single-gender groups for women suffering from opioid use fisorder: theory and treatment
10:55
to
11:05
Networking zone 3 (N3)
Efrat Fridma
11:05
Short communication
Systematic monitoring and feedback on data results as supportive tools for substance use disorder individuals
11:05
to
11:15
Networking zone 3 (N3)
Thomas Solgård Svendsen
11:15
Short communication
Patient-centered care for addictions treatment: findings from a scoping review
11:15
to
11:25
Networking zone 3 (N3)
Kirsten Marchand
11:25
Short communication
OST futures: integrating the user’s experience into person-centred care
11:25
to
11:35
Networking zone 3 (N3)
Karen Black
11:35
Short communication
Telephone delivered incentives for encouraging adherence to supervised methadone (TIES): development and feasibility study
11:35
to
11:45
Networking zone 3 (N3)
Nicola Metrebian
11:45
Short communication
Benzodiazepine use in an opioide maintenance programme: risks and clinical outcomes
11:45
to
11:55
Networking zone 3 (N3)
Catarina Oliveira
11:55
Short communication
Telephone-delivered contingency management to promote behaviour change in addiction treatment.
11:55
to
12:05
Networking zone 3 (N3)
Carol-Ann Getty
12:05
Short communication
Measuring personality problems in patients with substance use disorders
12:05
to
12:15
Networking zone 3 (N3)
Espen Ajo Arnevik